We performed 560 minimally invasive unicompartmental knee arthroplasties in patients with osteoarthritis using the Oxford phase 3 prosthesis since January 2002. For the prospective analysis, clinical and radiographic assessments were carried out preoperatively and regularly followed after surgery. Ninety-five cases were followed at 3, 6, 12, 24, and 36 months postoperatively. In this prospective study, the early postoperative results of minimally invasive Oxford phase 3 unicompartmental knee arthroplasty were satisfactory for improvement of knee score and function score of the American Knee Society (AKS) score, and recovery of knee motion. The AKS knee score and function score continued to improve for 3 years postoperatively.

Download full-text PDF

Source

Publication Analysis

Top Keywords

oxford phase
12
unicompartmental knee
12
prospective analysis
8
phase unicompartmental
8
knee arthroplasty
8
minimally invasive
8
knee score
8
score function
8
function score
8
knee
7

Similar Publications

Research into novel two-dimensional (2D) materials has boomed over the past decade, with a bewildering diversity of distinct properties being discovered. In this work, layered PtSe, grown by chemical vapor deposition and thermally converted to non-layered tetragonal PtSe, is experimentally and theoretically investigated. Notably, the resultant PtSe is distinctly metallic, which highlights the significance of sub-stoichiometric phases within transition metal dichalcogenide films.

View Article and Find Full Text PDF

Background: Primary care networks (PCNs) are increasingly being adopted in low- and middle-income countries (LMICs) to improve the delivery of primary health care (PHC). Kenya has identified PCNs as a key reform to strengthen PHC delivery and has passed a law to guide its implementation. PCNs were piloted in two counties in Kenya in 2020 and implemented nationally in October 2023.

View Article and Find Full Text PDF

Synaptic plasticity plays a fundamental role in neuronal dynamics, governing how connections between neurons evolve in response to experience. In this study, we extend a network model of θ-neuron oscillators to include a realistic form of adaptive plasticity. In place of the less tractable spike-timing-dependent plasticity, we employ recently validated phase-difference-dependent plasticity rules, which adjust coupling strengths based on the relative phases of θ-neuron oscillators.

View Article and Find Full Text PDF

Purpose: Involving patients in developing patient-reported outcome measures (PROMs) is essential for accurately capturing their perspectives. However, understanding how patients were involved in developing PROMs used after hip or knee arthroplasty is limited. This scoping review aimed to evaluate whether patients were involved in the development of these PROMs and how they were involved.

View Article and Find Full Text PDF

Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial.

Lancet Neurol

February 2025

Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada; Department of Cognitive Neurology, St Joseph's Health Care London, London, ON, Canada. Electronic address:

Background: No treatments exist for apathy in people with frontotemporal dementia. Previously, in a randomised double-blind, placebo-controlled, dose-finding study, intranasal oxytocin administration in people with frontotemporal dementia improved apathy ratings on the Neuropsychiatric Inventory over 1 week and, in a randomised, double-blind, placebo-controlled, crossover study, a single dose of 72 IU oxytocin increased blood-oxygen-level-dependent signal in limbic brain regions. We aimed to determine whether longer treatment with oxytocin improves apathy in people with frontotemporal dementia.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!